Eli Lilly Pakistan Chief Says Pricing Policy Deters Pharma Investments
This article was originally published in PharmAsia News
Executive Summary
An executive of Pakistan’s Pharma Bureau said the nation’s control on drug prices is deterring investment in the pharmaceutical sector.